Nanotechnology has the potential to circumvent several drawbacks of conventional
therapeutic formulations. In fact, significant strides have been made towards the application …

An important motivation for the use of nanomaterials and nanoarchitectures in cancer
therapy emanates from the widespread emergence of drug resistance. Although doxorubicin …

Many therapeutically active molecules are non-soluble in aqueous systems, chemically and
biologically fragile or present severe side effects. Lipid-based nanoparticle (LBNP) systems …

Hyaluronic acid (HA) also known as hyaluronan, is a natural polysaccharide—an anionic,
non-sulfated glycosaminoglycan—commonly found in our bodies. It occurs in the highest …

Hyaluronic acid (HA) is widely used in anticancer drug delivery, since it is biocompatible,
biodegradable, non-toxic, and non-immunogenic; moreover, HA receptors are …

Extracellular vesicles (EVs) are phospholipid-based particles endogenously produced by
cells. Their natural composition and selective cell interactions make them promising drug …

The acidic characteristic of the tumor site is one of the most well‐known features and
provides a series of opportunities for cancer‐specific theranostic strategies. In this regard …

Although hydrophilic small molecule drugs are widely used in the clinic, their rapid
clearance, suboptimal biodistribution, low intracellular absorption and toxicity can limit their …

Polysaccharides are natural biological molecules that have numerous advantages for
theranostics, the integrated approach of therapeutics and diagnostics. Their derivable …

Overcoming multidrug resistance is achieved by developing a novel drugdelivery-system
paradigm based on azobenzene liposome and phosphatidylcholine-modified upconversion …